Table 1.

Clinical Characteristics of 489 Samples Base on SLC16A3 Expression

Characteristics	SLC16A3
	Low Expression	High Expression	P-value
Age	60.30±7.01	61.66±6.60	0.028
T stage			0.320
T2	102	83
T3	136	152
T4	5	5
Tx	2	4
N stage			0.109
N0	173	167
N1	31	46
Nx	41	31
M stage			0.343
M0	223	225
M1	0	2
Mx	22	17
Gleason grade group			0.005
1	28	17
2	84	60
3	48	52
4	33	30
5	52	85
Overall survival			1
Alive	243	242
Dead	2	2
Disease-free survival			0.003
Disease-free	212	186
Recurred/progressed	33	58